Effect of praying on depression, anxiety and stress of mothers

Randomized clinical trial of the effects of prayer on depression, anxiety and stress in mothers of preterm infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014100719429N1

Enrollment

Registered

2015-01-07

Start date

2013-08-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Anxiety. Condition 3: Stress. Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified Other mental and behavioural disorders associated with the puerperium, not elsewhere classified Other mental and behavioural disorders associated with the puerperium, not elsewhere classified

Interventions

Intervention 1: Tavasol praying with Mr. Farahmand’s voice played by audio devices 20 minutes daily for 7 days. Intervention 2: No intervention for control group.

Prevention

Behavior

Tavasol praying with Mr. Farahmand’s voice played by audio devices 20 minutes daily for 7 days

No intervention for control group

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria of mother: • No more than two standard deviations from the mean difference of prayer questionnaire • Infants with gestational age less than 35 weeks • Obvious lack of psychiatric disorders such as psychosis , major depression , obsessive - compulsive , personality disorder characterized by a questionnaire SCL90 • A singleton baby • No obvious physical deformities newborn • Iranian nationality Exclusion criteria: • Infant death • Infants discharged during 7 days • Lack of cooperation and implementation of intervention by mother

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).;Depression. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).;Stress. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).	—

Measure

Time frame

Anxiety. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).;Depression. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).;Stress. Timepoint: At the beginning of the study, After intervention and 1 month later. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).

—

Secondary

Measure	Time frame
Evaluate adherence to pray. Timepoint: At the beginning of the study. Method of measurement: Prayer Questionnaire Mravgylya.;Evaluation of mental health. Timepoint: At the beginning of the study. Method of measurement: Mental health Questionnaire(SCL90).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Karbandi

Mashhad University of Medical Sciences

karbandis@mums.ac.ir+98 518591511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026